Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dronabinol - Vertanical GmbH

Next Previous
X
Search
Drug Profile

Dronabinol - Vertanical GmbH

Alternative Names: delta-9-Tetrahydrocannabinol; VER-01

Latest Information Update: 05 Dec 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Vertanical
  • Class Antidementias; Antiemetics; Antineoplastics; Appetite stimulants; Cannabinoids; Chromans; Muscle relaxants; Non-opioid analgesics; Small molecules
  • Mechanism of Action Cannabinoid receptor CB1 agonists; Cannabinoid receptor CB2 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Back pain

Most Recent Events

  • 18 Oct 2024 Vertanical completes the phase III ELEVATE trial in Back pain in Spain and Germany (PO, Solution) (NCT05610813) (EudraCT2022-001358-41)
  • 30 Jun 2024 Vertanical GmbH plans the phase II RESPONSE trial Back pain (PO), in June 2024 (NCT06475001) (EudraCT2023-507358-34)
  • 26 Mar 2024 Vertanical completes a Phase-III clinical trials in Back pain in Germany, Austria (PO) (EudraCT-2020-000107-36) (NCT04940741)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top